Clinical Trial Update: An Open-Label Trial Measuring Satisfaction And Convenience Of Two Formulations Of Lamotrigine In Subjects With A Mood Disorder [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial comparing two Lamotrigine formulations in mood disorders evaluated for satisfaction and convenience. The study is completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mood Disorders

Drugs mentioned

• Lamictal (lamotrigine) (lamotrigine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Mood Disorders | Phase 3 | Status: COMPLETED | Results posted: 2009-08-03